Stocks

Magazine articles on individual stocks, valuation, accounting standards, IPO's, brokerages, exchanges.

Old Articles: <Older 25851-25860 Newer>

The Motley Fool August 31, 2007 Anders Bylund	Dell Is Hungry Again "OK" results aren't good enough for Dell anymore. That's great news for shareholders.
The Motley Fool August 31, 2007 Dave Mock	Chunghwa's Still Chasing Growth Taiwan's largest telco looks for growth but finds competition. Chunghwa is a stock for patient investors who like a generous dividend while the company reforms itself to focus on dominating higher-growth sectors.
The Motley Fool August 31, 2007 David Lee Smith	Taking a Flyer on FedEx Among the few companies set to report in September, FedEx clearly bears watching.
The Motley Fool August 31, 2007 Rick Aristotle Munarriz	Peacock Spits Out Apple. Film at 11. NBC Universal is ready to kill off digital distribution of its programs through iTunes. Investors, take note.
The Motley Fool August 31, 2007 Joe Magyer	How to Stop Losing Money in Stocks If losing money causes us pain, and we don't like pain, we should try to avoid losing money, right? Four simple steps for lowering risk and boosting returns.
The Motley Fool August 31, 2007 Brian Lawler	Tercica Triumphs With the FDA Swiping patients from competitors is a key part of Tercica's plan to make its hormone disorder treatment a success.
The Motley Fool August 31, 2007 Tim Beyers	No Vacancy for iMergent at the Hotel California iMergent filed an 8-K, in which the company claims it will challenge the constitutionality of a California law that it has been found to violate, known principally as the "SAMP Act." Investors, take note.
The Motley Fool August 31, 2007 Brian Orelli	Guidelines to Stop the Wheezing Investors, new asthma guidelines will affect some drug makers. The FDA isn't the only organization that affects how well drugs do in the marketplace.
The Motley Fool August 31, 2007 Brian Lawler	QLT Gets Reformulated Drug developer QLT announced that an EU approval will open new markets for the cancer drug that could edge out the competition by lowering overall medical costs.
The Motley Fool August 31, 2007 Lawrence A. Rothman	Fred's Needs New Priorities The discount retailer goes generic and buys back shares. Will that really help?
<Older 25851-25860 Newer> Return to current articles.